Inhibition of platelet aggregation by clopiclogrel is unaffected by the CYP2C19 681G>A polyrnorphism in patients with coronary artery disease

被引：0
|
作者：
Smith, Simon M. G. [1 ]
Buckland, Robert [1 ]
Daly, Martina E. [1 ]
Storey, Robert F. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：375A / 375A
页数：1
相关论文
共 50 条
  • [31] Impact of CYP2C19 Polymorphism on Coronary Artery Spasm in Patients With Vasospastic Angina(VSA)
    Akasaka, Tomonori
    Hokimoto, Seiji
    Tsujita, Kenichi
    Kaikita, Koichi
    Iwasita, Satomi
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [32] Correlation between CYP2C19 gene polymorphism and clinical efficacy of clopidogrel in patients with coronary artery heart disease
    Sun, Kui
    Zhang, Pei-Pei
    Gong, Ya-Nan
    Wang, Xiang-Bo
    Meng, Yan
    Zhang, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (07): : 5290 - 5296
  • [33] THE IMPACT OF CYP2C19*2 POLYMORPHISM ON ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH CORONARY ARTERY DISEASE RECEIVING CLOPIDOGREL
    Zaromitidou, Marina
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Kioufis, Stamatios
    Oikonomou, Evangelos
    Maniatis, Konstantinos
    Miliou, Antigoni
    Kollia, Christina
    Michalea, Stavroula
    Zisimos, Konstantinos
    Kokkou, Eleni
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1409 - E1409
  • [34] Differential impact of omeprazole, pantoprazole and CYP2C19 on clopidogrel pharmacokinetics and pharmacodynamics in stable coronary artery disease patients
    Collet, J. -P
    Simon, N.
    Finzi, J.
    Cayla, C.
    Silvain, J.
    Montalescot, G.
    Hulot, J. S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 321 - 322
  • [35] Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients
    Shi, Yuliang
    Yang, Yuxian
    Feng, Miaoling
    Ling, Weihan
    Wei, Tongguo
    Cao, Yumin
    Zhong, Rui
    Wu, Heming
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3473 - 3481
  • [36] Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?
    Chouchene, Saoussen
    Dabboubi, Rym
    Raddaoui, Haythem
    Abroug, Hela
    Ben Hamda, Khaldoun
    Fredj, Sondess Hadj
    Abderrazak, Fatma
    Gaaloul, Mayssa
    Rezek, Marwa
    Neffeti, Fadoua
    Hellara, Ilhem
    Sassi, Mouna
    Khefacha, Linda
    Sriha, Asma
    Nouira, Semir
    Najjar, Mohamed Fadhel
    Maatouk, Faouzi
    Messaoud, Taieb
    Hassine, Mohsen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (12) : 1567 - 1574
  • [37] Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?
    Saoussen Chouchene
    Rym Dabboubi
    Haythem Raddaoui
    Hela Abroug
    Khaldoun Ben Hamda
    Sondess Hadj Fredj
    Fatma Abderrazak
    Mayssa Gaaloul
    Marwa Rezek
    Fadoua Neffeti
    Ilhem Hellara
    Mouna Sassi
    Linda Khefacha
    Asma Sriha
    Semir Nouira
    Mohamed Fadhel Najjar
    Faouzi Maatouk
    Taieb Messaoud
    Mohsen Hassine
    European Journal of Clinical Pharmacology, 2018, 74 : 1567 - 1574
  • [38] The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients
    Amin, Arwa M.
    Chin, Lim Sheau
    Noor, Dzul Azri Mohamed
    Mostafa, Hamza
    Kader, Muhamad Ali S. K. Abdul
    Hay, Yuen Kah
    Ibrahim, Baharudin
    THROMBOSIS RESEARCH, 2017, 158 : 22 - 24
  • [39] EFFECT OF CLOPIDOGREL OR TICAGRELOR ON PCI PLATELET INHIBITION RATE IN PATIENTS WITH DIFFERENT CYP2C19 ALLELES
    Jiang, Zhen
    Li, Sai
    Li, Yinjun
    Jin, Xiaoyu
    Bao, Bo
    Wang, Yang
    ACTA MEDICA MEDITERRANEA, 2020, 36 (01): : 299 - 303
  • [40] Relevance of CYP2C19*2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel
    Cano, Pedro
    Consuegra-Sanchez, Luciano
    Conesa, Pablo
    Torres-Moreno, Daniel
    Jaulent, Leticia
    Dau, Derek
    Pico, Francisco
    Villegas, Manuel
    MEDICINA CLINICA, 2014, 143 (01): : 6 - 12
12345